DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Balaji Phosphates Limited — Issue of Securities

NSE 3d ago·27 Aug 2026, 3:11 pm

Balaji Phosphates

Balaji Phosphates Limited has informed stock exchanges that it plans to issue new securities. This announcement signals the company's intent to raise capital, which could involve issuing fresh shares or convertible instruments to investors.

For investors, this move is significant as it dilutes the ownership stake of existing shareholders. The company will use the raised funds to support its business operations, fund expansion projects, or reduce debt. The impact on the stock price will depend on the purpose of the fund raising and the market's reception to the news.

Investors should watch for the company's official filing to understand the specific terms of the issue, such as the price band and the purpose of the funds. It is also important to monitor the stock's reaction to the announcement to gauge market sentiment towards the proposed capital raise.